Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...

Investors in Niagen Bioscience, Inc. NAGE need to pay close attention to the stock based on moves in the options market lately. That is because the Aug. 21, 2026 $12.50 Call had some of the highest ...

The ROTOR platform will initially be developed and validated using rotavirus vaccine datasets.

KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global ...

First consumer health product positions Daré for revenue generation while expanding its women's health leadership platform ...

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered ...

Niagen Bioscience is back in focus after analysts cut their combined price targets by US$5 while still holding the fair value estimate steady at US$12.60. The adjustment reflects fresh scrutiny of the ...

Company receives grant from the Gates Foundation to develop srRNA vaccine candidates for tuberculosis, subject to humanitarian licensing terms. SAN DIEGO, June 19, 2026 /PRNewswir ...

SAN FRANCISCO--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, ...

As America approaches its 250th anniversary, the companies will pursue the development of scalable seedling technologies to support the first-ever restoration of a native tree species from functional ...

NAD+ levels fall up to 65% as we age. Learn the clinical science behind Niagen Bioscience's NAD precursor and how it fights ...

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.